PMID- 25586717 OWN - NLM STAT- MEDLINE DCOM- 20151112 LR - 20240322 IS - 1557-1904 (Electronic) IS - 1557-1890 (Print) IS - 1557-1890 (Linking) VI - 10 IP - 1 DP - 2015 Mar TI - Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-gamma via a TNF-alpha/JNK- mediated mechanism. PG - 55-73 LID - 10.1007/s11481-014-9573-x [doi] AB - Cocaine abuse represents an immense societal health and economic burden for which no effective treatment currently exists. Among the numerous intracellular signaling cascades impacted by exposure to cocaine, increased and aberrant production of pro-inflammatory cytokines in the CNS has been observed. Additionally, we have previously reported a decrease in retinoid-X-receptor-gamma (RXR-gamma) in brains of mice chronically exposed to cocaine. Through obligate heterodimerization with a number of nuclear receptors, RXRs serve as master regulatory transcription factors, which can potentiate or suppress expression of a wide spectrum of genes. Little is known about the regulation of RXR levels, but previous studies indicate cellular stressors such as cytokines negatively regulate levels of RXRs in vitro. To evaluate the mechanism underlying the cocaine-induced decreases in RXR-gamma levels observed in vivo, we exposed neurons to cocaine in vitro and examined pathways which may contribute to disruption in RXR signaling, including activation of stress pathways by cytokine induction. In these studies, we provide the first evidence that cocaine exposure disrupts neuronal RXR-gamma signaling in vitro by promoting its nuclear export and degradation. Furthermore, we demonstrate this effect may be mediated, at least in part, by cocaine-induced production of TNF-alpha and its downstream effector c-Jun-NH-terminal kinase (JNK). Findings from this study are therefore applicable to both cocaine abuse and to pathological conditions characterized by neuroinflammatory factors, such as neurodegenerative disease. FAU - Kovalevich, Jane AU - Kovalevich J AD - Department of Neuroscience, Temple University School of Medicine, Medical Education Research Building, 3500 North Broad Street, Philadelphia, PA, 19140, USA. FAU - Yen, William AU - Yen W FAU - Ozdemir, Ahmet AU - Ozdemir A FAU - Langford, Dianne AU - Langford D LA - eng GR - P30 MH092177/MH/NIMH NIH HHS/United States GR - R21 DA029523/DA/NIDA NIH HHS/United States GR - DA029523/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20150114 PL - United States TA - J Neuroimmune Pharmacol JT - Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology JID - 101256586 RN - 0 (Cytokines) RN - 0 (GAP-43 Protein) RN - 0 (Retinoid X Receptor gamma) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - I5Y540LHVR (Cocaine) SB - IM MH - Animals MH - Cell Line MH - Cell Nucleus/*metabolism MH - Cocaine/*pharmacology MH - Cytokines/metabolism MH - GAP-43 Protein/metabolism MH - Gene Expression Regulation/drug effects MH - Immunohistochemistry MH - JNK Mitogen-Activated Protein Kinases/*metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Neurons/drug effects/*metabolism MH - Plasmids/genetics MH - Retinoid X Receptor gamma/genetics/*metabolism MH - Signal Transduction/drug effects MH - Tumor Necrosis Factor-alpha/*metabolism PMC - PMC4336643 MID - NIHMS655666 COIS- The authors declare that they have no conflicts of interest. EDAT- 2015/01/15 06:00 MHDA- 2015/11/13 06:00 PMCR- 2016/03/01 CRDT- 2015/01/15 06:00 PHST- 2014/05/27 00:00 [received] PHST- 2014/11/26 00:00 [accepted] PHST- 2015/01/15 06:00 [entrez] PHST- 2015/01/15 06:00 [pubmed] PHST- 2015/11/13 06:00 [medline] PHST- 2016/03/01 00:00 [pmc-release] AID - 10.1007/s11481-014-9573-x [doi] PST - ppublish SO - J Neuroimmune Pharmacol. 2015 Mar;10(1):55-73. doi: 10.1007/s11481-014-9573-x. Epub 2015 Jan 14.